Indraprastha Medical Corporation Limited has formally notified stock exchanges about an upcoming board meeting scheduled for May 12, 2026. The announcement, made in compliance with regulatory requirements, outlines key agenda items for the meeting including financial results approval and dividend considerations.

Board Meeting Details

The company has issued an official intimation to both BSE Limited and National Stock Exchange of India Limited regarding the board meeting. The notification, dated May 1, 2026, was signed by Priya Ranjan, AVP – Corporate Affairs & Legal, who serves as the Company Secretary & Compliance Officer.

Key Agenda Items

The board meeting will address two primary matters of significant importance to shareholders and stakeholders:

• Financial Results Approval: The board will consider and approve audited financial results for the quarter and year ended March 31, 2026
• Dividend Recommendation: Directors will deliberate on potential dividend recommendations for equity shareholders for the financial year 2025-26

Regulatory Compliance

The intimation has been issued pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to inform stock exchanges about board meetings where financial results will be considered, ensuring transparency and timely disclosure to market participants.

Company Information

Indraprastha Medical Corporation Limited, also known as Indraprastha Apollo Hospitals, operates from its registered office at Sarita Vihar, Delhi-Mathura Road, New Delhi. The company maintains its corporate identity under CIN L24232DL1988PLC030958 and is accredited by Joint Commission International, reflecting its commitment to healthcare quality standards.

Indraprastha Medical Corporation Limited has filed its quarterly dematerialisation compliance certificate with stock exchanges, maintaining its regulatory obligations under SEBI guidelines. The healthcare services company submitted the mandatory documentation for the quarter ended 31st March 2026.

Regulatory Compliance Filing

The company submitted its confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 to both BSE and NSE on 7th April 2026. The certificate was issued by MUFG Intime India Private Limited, formerly Link Intime India Private Limited, which serves as the company's registrar and share transfer agent.

Certificate Confirmation

MUFG Intime India Private Limited confirmed that securities received from depository participants for dematerialisation during the quarter were properly processed according to regulatory requirements. The registrar verified that all security certificates received for dematerialisation were confirmed or rejected within prescribed timelines.

The certificate confirms that securities comprised in the certificates have been listed on stock exchanges where the company's earlier issued securities are already listed. Additionally, the registrar confirmed that security certificates received were mutilated and cancelled after due verification by depository participants.

Stock Exchange Details

The filing was submitted to both major Indian stock exchanges where the company's shares are traded. The company maintains its listing compliance across these platforms, ensuring transparency and regulatory adherence for its shareholders and market participants.

The submission was signed by Priya Ranjan, AVP – Corporate Affairs & Legal, who serves as the Company Secretary & Compliance Officer. This quarterly filing demonstrates the company's commitment to maintaining regulatory compliance and transparency in its securities operations.